18.62
-0.19(-1.01%)
Currency In USD
Previous Close | 18.81 |
Open | 18.71 |
Day High | 19.02 |
Day Low | 18.17 |
52-Week High | 130 |
52-Week Low | 6.76 |
Volume | 584,149 |
Average Volume | 1.49M |
Market Cap | 163.22M |
PE | 0.01 |
EPS | 2,537 |
Moving Average 50 Days | 30.23 |
Moving Average 200 Days | 27.67 |
Change | -0.19 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of October 18, 2025 at a share price of $18.62. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.04 as of October 18, 2025 at a share price of $18.62.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
TNX-801 is a live virus vaccine investigational candidate, designed to provide durable protection against mpox and smallpox TNX-801 demonstrated favorable safety, immunogenicity, and long-term protection in multiple preclinical models Data support ad
Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
GlobeNewswire Inc.
Oct 14, 2025 11:00 AM GMT
CHATHAM, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated biotechnology company with marketed products and a pipeline of development candidates, today announce
Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025
GlobeNewswire Inc.
Oct 09, 2025 11:00 AM GMT
CHATHAM, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announce